Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Angiomyolipoma in TSC/LAM
NCT00457808Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in tuberous sclerosis complex (TSC), lymphangioleiomyomatosis (LAM), sponsored by Cincinnati Children's Hospital Medical Center. Started Dec 2002; status: completed.
02
Drugs
sirolimus
03
Conditions
tuberous sclerosis complex (TSC)lymphangioleiomyomatosis (LAM)
Beyond the preview
Go deeper on NCT00457808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00457808.